The First Hospital of China Medical University, Shenyang, 110122, China.
Department of Reproductive Biology and Transgenic Animal, China Medical University, Shenyang, 110122, China.
J Exp Clin Cancer Res. 2020 Jun 10;39(1):108. doi: 10.1186/s13046-020-01613-y.
Chemo-resistance of bladder cancer has been considered to be one of the serious issues to be solved. In this study, we revealed pivotal role of miR-424 in the regulation of CDDP sensitivity of bladder cancer cells.
The cytotoxicity of cisplatin and effect of miR-424 were assessed by flow cytometry and TUNEL. Transcriptional regulation of miR-424 by HIF-1α was assessed by Chromatin immunoprecipitation (ChIP). Effect of miR-424 on expression of UNC5B, SIRT4 (Sirtuin4) and apoptotic markers was measured by QRT-PCR and/or Western blot. The regulation of miR-424 for UNC5B and SIRT4 were tested by luciferase reporter assay. The 5637-inoculated nude mice xenograft model was used for the in vivo study. The clinical significance of miR-424 was demonstrated mainly through data mining and statistical analysis of TCGA.
In this study, we have found for the first time that cisplatin (CDDP) induces the expression of miR-424 in a HIF-1α-dependent manner under normoxia, and miR-424 plays a vital role in the regulation of CDDP resistance of bladder cancer cells in vitro. Mechanistically, we have found that UNC5B and SIRT4 are the direct downstream target genes of miR-424. CDDP-mediated suppression of xenograft bladder tumor growth was prohibited by the addition of miR-424, whereas ectopic expression of UNC5B or SIRT4 partially restored miR-424-dependent decrease in CDDP sensitivity of bladder cancer 5637 and T24 cells. Moreover, knockdown of UNC5B or SIRT4 prohibited CDDP-mediated proteolytic cleavage of PARP and also decreased CDDP sensitivity of these cells. Consistently, the higher expression levels of miR-424 were closely associated with the poor clinical outcome of the bladder cancer patients. There existed a clear inverse relationship between the expression levels of miR-424 and pro-apoptotic UNC5B or SIRT4 in bladder cancer tissues.
Collectively, our current results strongly suggest that miR-424 tightly participates in the acquisition/maintenance of CDDP-resistant phenotype of bladder cancer cells through down-regulation of its targets UNC5B and SIRT4, and thus combination chemotherapy of CDDP plus HIF-1α/miR-424 inhibition might have a significant impact on hypoxic as well as normoxic bladder cancer cells.
膀胱癌的化疗耐药性一直被认为是亟待解决的严重问题之一。在这项研究中,我们揭示了 miR-424 在调节膀胱癌细胞对顺铂敏感性中的关键作用。
通过流式细胞术和 TUNEL 评估顺铂的细胞毒性和 miR-424 的作用。通过染色质免疫沉淀(ChIP)评估 miR-424 对 HIF-1α 的转录调控。通过 QRT-PCR 和/或 Western blot 测量 miR-424 对 UNC5B、SIRT4(Sirtuin4)和凋亡标志物表达的影响。通过荧光素酶报告基因检测测试 miR-424 对 UNC5B 和 SIRT4 的调节。使用 5637 接种的裸鼠异种移植模型进行体内研究。通过 TCGA 数据挖掘和统计分析主要证明了 miR-424 的临床意义。
在这项研究中,我们首次发现顺铂(CDDP)在常氧条件下以 HIF-1α 依赖的方式诱导 miR-424 的表达,并且 miR-424 在体外调节膀胱癌细胞对 CDDP 耐药性方面发挥着重要作用。在机制上,我们发现 UNC5B 和 SIRT4 是 miR-424 的直接下游靶基因。添加 miR-424 可阻止 CDDP 介导的异种移植膀胱癌肿瘤生长的抑制,而 UNC5B 或 SIRT4 的异位表达部分恢复了 miR-424 依赖的膀胱癌 5637 和 T24 细胞对 CDDP 敏感性的降低。此外,UNC5B 或 SIRT4 的敲低可阻止 CDDP 介导的 PARP 蛋白水解裂解,并且还降低了这些细胞对 CDDP 的敏感性。一致地,miR-424 表达水平的升高与膀胱癌患者的不良临床结局密切相关。在膀胱癌组织中,miR-424 的表达水平与促凋亡 UNC5B 或 SIRT4 之间存在明显的负相关关系。
总的来说,我们的研究结果强烈表明,miR-424 通过下调其靶基因 UNC5B 和 SIRT4,紧密参与膀胱癌细胞获得/维持 CDDP 耐药表型,因此 CDDP 联合 HIF-1α/miR-424 抑制的联合化疗可能对缺氧和常氧膀胱癌细胞产生重大影响。